Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julia Witjes"'
Autor:
Daniela Stols-Gonçalves, Anne Linde Mak, Mette S. Madsen, Eduard W. J. van der Vossen, Eveline Bruinstroop, Peter Henneman, Femke Mol, Torsten P. M. Scheithauer, Loek Smits, Julia Witjes, Abraham Stijn Meijnikman, Joanne Verheij, Max Nieuwdorp, Adriaan G. Holleboom, Evgeni Levin
Publikováno v:
Gut Microbes, Vol 15, Iss 1 (2023)
ABSTRACTIndividuals with nonalcoholic fatty liver disease (NAFLD) have an altered gut microbiota composition. Moreover, hepatic DNA methylation may be altered in the state of NAFLD. Using a fecal microbiota transplantation (FMT) intervention, we aime
Externí odkaz:
https://doaj.org/article/614e1712deb34c56a7a373a90e4405b5
Autor:
Erik S.G. Stroes, Carlos Pérez-Medina, Sean Carlin, Zahi A. Fayad, Andreas Kjaer, Jason Bini, Julia Witjes, Chang Ho Wessel, Luuk Giesen, Francois Fay, Tina Binderup, Thomas Reiner, Mark E. Lobatto, Philip M. Robson, Gert Storm, Willem J. M. Mulder, Mootaz Eldib, Samantha Baxter, Jason S. Lewis, Claudia Calcagno
Publikováno v:
Bioconjugate Chemistry, 31(2), 360-368. American Chemical Society
Bioconjugate chemistry, 31(2), 360-368. American Chemical Society
Bioconjugate Chemistry, 31(2), 360. American Chemical Society : Division of Carbohydrate Chemistry
Bioconjug Chem
Bioconjugate chemistry, 31(2), 360-368. American Chemical Society
Bioconjugate Chemistry, 31(2), 360. American Chemical Society : Division of Carbohydrate Chemistry
Bioconjug Chem
Nanotherapy has recently emerged as an experimental treatment option for atherosclerosis. To fulfill its promise, robust noninvasive imaging approaches for subject selection and treatment evaluation are warranted. To that end, we present here a posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b3f7f41f55eb3710de7ae2f448bc3a
https://doi.org/10.1021/acs.bioconjchem.9b00256
https://doi.org/10.1021/acs.bioconjchem.9b00256
Autor:
Annefleur, Koopen, Julia, Witjes, Koen, Wortelboer, Soumia, Majait, Andrei, Prodan, Evgeni, Levin, Hilde, Herrema, Maaike, Winkelmeijer, Steven, Aalvink, Jacques J G H M, Bergman, Stephan, Havik, Bolette, Hartmann, Han, Levels, Per-Olof, Bergh, Jamie, van Son, Manon, Balvers, Diogo Mendes, Bastos, Erik, Stroes, Albert K, Groen, Marcus, Henricsson, Ellis Marleen, Kemper, Jens, Holst, Christopher M, Strauch, Stanley L, Hazen, Fredrik, Bäckhed, Willem M, De Vos, Max, Nieuwdorp, Elena, Rampanelli
Publikováno v:
Gut. 71(8)
Although gut dysbiosis is increasingly recognised as a pathophysiological component of metabolic syndrome (MetS), the role and mode of action of specific gut microbes in metabolic health remain elusive. Previously, we identified the commensal butyrog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::acf58cfa33f7b5a1d8b50b6c974378aa
https://pubmed.ncbi.nlm.nih.gov/34697034
https://pubmed.ncbi.nlm.nih.gov/34697034
Autor:
Judith, Aron-Wisnewsky, Chloé, Vigliotti, Julia, Witjes, Phuong, Le, Adriaan G, Holleboom, Joanne, Verheij, Max, Nieuwdorp, Karine, Clément
Publikováno v:
Nature reviews. Gastroenterologyhepatology. 17(5)
Gut microbiota dysbiosis has been repeatedly observed in obesity and type 2 diabetes mellitus, two metabolic diseases strongly intertwined with non-alcoholic fatty liver disease (NAFLD). Animal studies have demonstrated a potential causal role of gut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::098761a56643743aab08faa177fe8242
https://pubmed.ncbi.nlm.nih.gov/32152478
https://pubmed.ncbi.nlm.nih.gov/32152478